Evidence map›Paper›PMID 25680814›Full record

ArticleGenetics2015

A role for the serine/arginine-rich (SR) protein B52/SRSF6 in cell growth and myc expression in Drosophila.

Céline Fernando, Agnès Audibert, Françoise Simon, Jamal Tazi, François Juge

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Targeting Splicing Factor SRSF6 for Cancer Therapy.Frontiers in cell and developmental biology · 2021
    Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Céline FernandoInstitut de Génétique Moléculaire de Montpellier, Unité Mixte de Recherche 5535, Centre National de la Recherche Scientifique, 1919 route de Mende, 34293 Montpellier Cedex 5, France Université de Montpellier, 163 rue Auguste Broussonnet, 34090 Montpellier, France.
Agnès AudibertSorbonne Universités, Université Pierre et Marie Curie Paris 06, Centre National de la Recherche Scientifique Unité Mixte de Recherche 7622, Laboratoire de Biologie du Développement, F-75005, Paris, France.
Françoise SimonSorbonne Universités, Université Pierre et Marie Curie Paris 06, Centre National de la Recherche Scientifique Unité Mixte de Recherche 7622, Laboratoire de Biologie du Développement, F-75005, Paris, France.
Jamal TaziInstitut de Génétique Moléculaire de Montpellier, Unité Mixte de Recherche 5535, Centre National de la Recherche Scientifique, 1919 route de Mende, 34293 Montpellier Cedex 5, France Université de Montpellier, 163 rue Auguste Broussonnet, 34090 Montpellier, France francois.juge@igmm.cnrs.fr jamal.tazi@igmm.cnrs.fr.
François JugeInstitut de Génétique Moléculaire de Montpellier, Unité Mixte de Recherche 5535, Centre National de la Recherche Scientifique, 1919 route de Mende, 34293 Montpellier Cedex 5, France Université de Montpellier, 163 rue Auguste Broussonnet, 34090 Montpellier, France francois.juge@igmm.cnrs.fr jamal.tazi@igmm.cnrs.fr.
Institut de Génétique Moléculaire de Montpellier · FRUniversité de Montpellier · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serine-/arginine-rich (SR) proteins are RNA-binding proteins that are primarily involved in alternative splicing. Expression of some SR proteins is frequently upregulated in tumors, and previous reports have demonstrated that these proteins can directly participate in cell transformation. Identifying factors that can rescue the effects of SR overexpression in vivo is, therefore, of potential therapeutic interest. Here, we analyzed phenotypes induced by overexpression of the SR protein B52 during Drosophila development and identified several proteins that can rescue these phenotypes. Using the mechanosensory bristle lineage as a developmental model, we show that B52 expression level influences cell growth, but not differentiation, in this lineage. In particular, B52 overexpression increases cell growth, upregulates myc transcription, and gives rise to flies lacking thoracic bristles. Using a genetic screen, we identified several suppressors of the phenotypes induced by overexpression of B52 in vivo in two different organs. We show that upregulation of brain tumor (brat), a tumor suppressor and post-transcriptional repressor of myc, and downregulation of lilliputian (lilli), a subunit of the superelongation complex involved in transcription elongation, efficiently rescue the phenotypes induced by B52 overexpression. Our results demonstrate a role of this SR protein in cell growth and identify candidate proteins that may overcome the effects of SR protein overexpression in mammals.

Indexed as

Gene Expression Regulation, DevelopmentalAnimalsCell DifferentiationCell Growth ProcessesCell LineageDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsMechanoreceptorsNuclear ProteinsPhenotypePhosphoproteinsProto-Oncogene Proteins c-mycRNA Splicing FactorsTranscription FactorsB52 protein, Drosophilabrat protein, DrosophilaDNA-Binding ProteinsDrosophila Proteinslilli protein, DrosophilaNuclear ProteinsPhosphoproteinsProto-Oncogene Proteins c-mycRNA Splicing FactorsTranscription Factorscell growthgenetic screenMycSR protein

Identifiers

PMID25680814
PMCPMC4391563
OpenAlexW2126539544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.